Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Pediatric vaccine product containing only diptheria standard dose + pertussis standard dose + tetanus + hepatitis B + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
TETRAMUNE suspension for injection Wyeth-Ayerst Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
DTaP-Hib ACTacel SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
TETRAMUNE suspension for injection Wyeth-Ayerst Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Inf INFLUVAC BGP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Inf INFLUVAC BGP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
HA EPAXAL BB |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Inf AGRIFLU SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Inf AGRIFLU SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Inf AGRIFLU SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Inf INFLUVAC BGP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DTaP-Hib ACTacel SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DTwP-HB Tritanrix GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DTwP-HB Tritanrix GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
AVAXIM 160 units per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
8 |
INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Pediatric vaccine product containing whole cell pertussis standard dose antigen (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DTwP-HB diptheria + tetanus + whole cell pertussis + hepatitis B pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
HAHB Hepatitis A + B regular strength unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DTwP-HB diptheria + tetanus + whole cell pertussis + hepatitis B pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Adult vaccine product containing only Hepatitis B virus regular strength antigen (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DPT-Hib suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DPT-Hib suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
DTaP-Hib diphtheria + tetanus + acellular pertussis + Haemophilus influenzae type b pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
DTaP-Hib diphtheria + tetanus + acellular pertussis + Haemophilus influenzae type b pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
RECOMBIVAX HB 10 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFANRIX-IPV suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
5 |
INFANRIX-IPV suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Pediatric vaccine product containing acellular pertussis antigen in standard dose (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Epaxal Berna 500 radioimmunoassay units per 0.5 milliliter suspension for injection Swiss Serum and Vaccine Institute Berne (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
DPTPH DPT-Polio-Hib AP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
DPTPH DPT-Polio-Hib AP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DCaT-VPI-Hib PENTACEL SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
DCaT-VPI-Hib PENTACEL SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing only diphtheria standard dose + tetanus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
DTaP-IPV KINRIX GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
DTaP-IPV KINRIX GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
5 |
Inf FLUAD SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Inf FLUAD SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Inf FLUAD SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus + Haemophilus influenza type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus + Haemophilus influenza type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Engerix B 20 micrograms per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
6 |
Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + inactivated human poliovirus + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |